| abstract |
The invention relates to the field of medicine and more particularly to novel combinations and combinatory treatments useful for treating lymphoma. More particularly, the invention thus relates to a combination comprising at least one inhibitor of glutamine metabolism or a pharmaceutically acceptable salt, prodrug, derivative, or sustained release formulation thereof and at least one inhibitor of mitochondrial electron transport chain or a pharmaceutically acceptable salt, prodrug, derivative, or sustained release formulation thereof, for its use in the treatment or the prevention of a lymphoma in a subject in need thereof. |